Abstract
Spurred by recent advances in materials chemistry, molecular pharmaceutics and nanobiotechnology, stimuli-responsive “smart” systems offer opportunities for delivering drugs in dose-, spatial- and temporal-controlled fashions. In this talk, Professor Gu will present their ongoing efforts in using physiological signals, such as blood sugar level, enzyme activity and ATP gradient for on-demand drug release. The first half of the talk will cover the glucose-responsive synthetic systems for biomimetic delivery of insulin for diabetes treatment which will be followed by programmed delivery of anticancer therapeutics, the release of which can be activated in the tumor microenvironment or subcellular environment.
For more information email technicalworkshops@sial.com.